Complete Story

2012 Program Schedule & CE Descriptions

FRIDAY,  April 20

8:15 a.m. (CE Credit per Program:  0.15 CEU)

Borderline Personality: Into the Chaos
(repeated at 9:55 a.m.)

Randy A. Sansone, M.D., Professor, Psychiatry & Internal Medicine, Wright State University School of Medicine
This presentation will examine the characteristics of individuals suffering from Borderline Personality Disorder, with a special emphasis on the risk of substance/prescription abuse in this population.
ACPE #0129-0000-12-028-L01-P

PRO:  Addiction Help for Pharmacists
Nick Kallis, R.Ph. and Jarrod Grossman, PharmD, R.Ph., Pharmacists Rehabilitation Organization
Addiction of health care professionals is a challenge for the individual, as well as their family, friends, and health care providers. This session will include an overview of addiction, prescription and over-the-counter drug therapy to use and avoid, and recovery resources for the individual involved.
ACPE #0129-0000-12-029-L01-P
Supported by Pharmacists Rehabilitation Organization and Cornerstone of Recovery

Hyperlipidemia Consensus Guidelines and Niacin Controversy
Ryan Schneider, PharmD, PhD, Assistant Professor of Pharmaceutical Sciences, UF College of Pharmacy
This session will provide a refresher on the current consensus guidelines for the management of hyperlipidemia, and will review the pharmacology and pharmacotherapy of antihyperlipidemic therapy.  Recent updates to simvastatin labeling and results from the AIM-HIGH study involving the combination of a statin and high dose, extended-release niacin will also be discussed.
ACPE #0129-0000-12-030-L01-P

9:55 a.m. (CE Credit per Program:  0.15 CEU)

Borderline Personality:  Into the Chaos
(repeat of 8:15 a.m. program)

Antithrombotic Therapy:  It’s Not Just Aspirin, Warfarin, and Heparin Anymore! (repeated at 1:00 p.m.)
Vincent F. Mauro, R.Ph., PharmD, FCCP, Professor of Clinical Pharmacy, UT College of Pharmacy
Over the past several years (and especially over the past few months), several new antithrombotic medications have become available for use in the United States.  This session will review the pharmacological activity and pharmacotherapeutic utilization of antithrombotic medications with a focus on the newer agents.  Case studies will be utilized to emphasize important pharmacotherapeutic perspectives.
ACPE #0129-0000-12-032-L01-P
Application-based activity

2012 OTC and Self-Care Challenge
Kristin Casper, R.Ph., PharmD, Associate Professor of Clinical Pharmacy, OSU College of Pharmacy; and Andrea Wall, R.Ph., Assistant Dean for Student and Alumni Affairs, UC College of Pharmacy
Come learn up-to-date information about nonprescription products, along with the rationale for product choices, at OPA’s 6th annual “OTC and Self-Care Challenge – Battle of the Colleges!” Join us for a highly interactive, fun-filled session that will enhance your OTC expertise and update your knowledge of common self-care conditions. Students and alumni will join in the friendly competition.
ACPE #0129-0000-12-033-L01-P
Supported by NASPA and Procter & Gamble

PBMs:  Who’s on First
Zachary French, Vice President, PBM Transparency Initiatives, National Community Pharmacists Association
This program brings a unique opportunity to hear the perspectives of the PBM industry and gain critical insight into the decision making that supports the plan designs that affect pharmacy practice.  A PBM insider will shed light on the role of key players in the pharmacy benefit decision-making process, the Pharmacy Benefit Consultant and the Plan Sponsor and help you to understand how they make the decisions that affect how you do business.  Tools and tactics that you can use to change your relationship with local payers, and promote attractive alternatives to mandatory mail order plan designs, will be reviewed.
ACPE #0129-0000-12-034-L04-P

1:00 p.m. (CE Credit per Program:  0.15 CEU)

Antithrombotic Therapy:  It’s Not Just Aspirin, Warfarin, and Heparin Anymore!
(repeat of 9:55 a.m. program)

Essence of Leadership
Milap C. Nahata, PharmD, MS Director, Institute of Therapeutic Innovations and Outcomes, OSU College of Pharmacy
All pharmacists can be leaders in their own ways. This interactive program is designed to improve your knowledge about the attributes of successful leaders so you can enhance your own leadership skills regardless of your position.
ACPE #0129-0000-12-035-L04-P

Pharmacists Affecting Care Transitions:  Building the Bridge Together
Joseph Dula, R.Ph., PharmD, Regional Director of Clinical Services, Pharmacy Systems, Inc. and Larry Schieber, R.Ph., Owner and Operator, Schieber Family Pharmacy, Circleville
The impact of pharmacists on medication adherence and prevention of medication-related problems is well documented in the literature, yet consistent application of this resource is difficult to achieve. A transition of care model implemented in Circleville, Ohio aims to improve the quality of care through collaboration between inpatient and community pharmacies.  An inpatient Clinical Support Pharmacist conducts a comprehensive medication review and face-to-face counseling with the patient.  This activity improves the medication reconciliation process and creates an opportunity to refer to the outpatient pharmacy for continuity of care.  The outpatient pharmacist, utilizing electronic access to hospital records, conducts medication therapy management activities to prevent readmission to the hospital.  This session will explore the implementation and highlight the achievements of this program to date.
ACPE #0129-0000-12-036-L04-P

Aspects and Management of Pain in the Hospice Setting
Maureen L. Jones, R.Ph., PharmD, Clinical Pharmacist, HospiScript, a Catalyst Rx Company
Part of a three-program module on pain management, this program will focus on the effective management of pain in hospice patients. Topics include assessing pain and anticipating common types of pain for terminal diseases, recognizing spiritual, emotional, and social pain and the role of interdisciplinary teams to address these issues, selecting effective pain management regimens, establishing monitoring parameters and managing the side effects of therapy, completing comprehensive medication reviews to discontinue unnecessary treatments, and reviewing laws surrounding CII narcotic dispensing for hospice patients. Case studies will highlight the presentation.
ACPE #0129-0000-12-037-L01-P
Application-based activity

2:40 p.m. (CE Credit per Program:  0.15 CEU)

Ohio Research Forum 2012
Moderator: Curtis Black, R.Ph., PhD, Distinguished University Professor Emeritus, UT College of Pharmacy
Ohio pharmacists, college faculty, pharmacy residents and students showcase their cutting-edge and innovative research in the annual Ohio Research Forum. Topics explored may include medication therapy management, proper drug therapy, pharmacoeconomic issues, technology in the profession, innovative pharmacy services, and others. The Poster Session, located outside the Exhibit Hall, immediately follows this platform session.   
ACPE #0129-0000-12-038-L04-P
Sponsor: Procter & Gamble

Optimizing the Role of Pharmacists: the APhA Foundation’s Project IMPACTTM Diabetes Model and Beyond
Mindy D. Smith, BSPharm, R.Ph., Executive Director and Benjamin M. Bluml, R.Ph., VP Research, American Pharmacists Association Foundation
Representatives from the APhA Foundation will present the innovative care models being used in Project IMPACTTM Diabetes and past APhA Foundation demonstration projects. Ben Bluml and Mindy Smith will outline emerging opportunities to implement these types of programs in your practice setting. A panel of guests who are currently engaged in the IMPACT care model will be on hand to provide more insight into the benefits and barriers to optimizing the role of pharmacists on the health care team.
ACPE #0129-0000-12-039-L04-P

Pharmacists’ Critical Role in Patient Care:  Federal Perspective
John Michael O’Brien, PharmD, MPH, National Field Director, CMS Innovation Center
Our speaker is one of the top pharmacist officials at the Center for Medicare and Medicaid Innovation (CMMI). His presentation will focus on the pharmacist’s critical role in improving the transition from home to hospital, and hospital to extended care or home. Many errors and omissions in care are being corrected by pharmacists, and this program will emphasize new areas for service and reimbursement.    ACPE #0129-0000-12-040-L04-P

Immunization Update
Debra L. Parker, R.Ph., PharmD, Chair & Assistant Professor, UF College of Pharmacy; and Darrin Rosebrook, Impact SIIS Trainer
The goal of this activity is to update clinicians on the 2011-2012 immunization recommendations from the Centers for Disease Control and Prevention. This program will provide the audience with the latest updates on immunization formulations, delivery schedules, target populations as well as information on the latest in routes of delivery. Pharmacists will also learn how to use Impact SIIS, an interactive system managed by the Ohio Department of Health for administering, delivering and tracking vaccinations.
ACPE #0129-0000-12-041-L01-P
Application-based activity

SATURDAY,  April 21

 8:15 a.m. (CE Credit per Program:  0.15 CEU)

Ohio Law Update 2012
(repeated at 9:55 a.m.)
Kyle W. Parker, MBA, R.Ph., Executive Director, Ohio State Board of Pharmacy
Our speaker will share key points about recent and proposed changes in state and federal pharmacy laws and regulations. This session is a must for all pharmacists who want to know how these changes affect everyday pharmacy practice. Bring your questions! This program has been approved by the State Board of Pharmacy for 0.15 CEU of Ohio jurisprudence CE credit.
ACPE #0129-0000-12-042-L03-P
Application-based activity

Health Care Reform - Creating New Roles for Pharmacists!
Jenelle Sobotka, PharmD, Professor and Endowed Chair, Department of Pharmacy Practice, ONU and President of APhA; and Chester Kaczor, PharmD, MBA, Regional Director of Clinical Services, Pharmacy Systems, Inc.
This program will review the status of adopted national policy and regulations for changes in health care delivery models.  Case examples of the new transition of care and patient care practice models will be shared with guidance on successful implementation. Approaches to developing a business plan and potential reimbursement options will be presented.
ACPE #0129-0000-12-043-L04-P

From the Body to the Eye: Ocular Medication and Common Ocular Side Effects of Systemic Medications
Rachel Dietz, R.Ph., PharmD, Staff Pharmacist, Walgreens
Our sight is one of our most precious gifts. Protect the sight of your patients by attending this session. Pharmacists and students will learn not only about common eye medications, but about little-known major ocular side effects of systemic medications.
ACPE #0129-0000-12-044-L01-P

Aspects and Management of Acute Injury Pain
Mary C. Borovicka, PharmD, BCPS, BCPP; Associate Professor, UT College of Pharmacy and Pharmaceutical Sciences
Part of a three-program module on pain management, this program will focus on the effective management of acute injury pain. Topics include an overview of the pathophysiology of acute injury pain, proper methods of pain assessment, rational medication selection, anticipation and avoidance of side effects, opioid conversion and useful tips for managing injury-related pain.  Case studies will highlight the presentation.
ACPE #0129-0000-12-045-L01-P
Application-based activity

9:55 a.m. (CE Credit per Program:  0.15 CEU)

Ohio Law Update 2012
(repeat of 8:15 a.m. program)

Bath Salts and SOAPing
Jon E. Sprague, R.Ph., PhD, ONU Professor of Pharmacology & Dean, College of Pharmacy
In 2011, the number of emergency department visits as a result of exposure to “bath salts” dramatically increased.  This program will explain the basic pharmacological and toxicological mechanisms by which these agents induce drug-seeking behavior and toxicity.  An overdose case associated with the use of bath salts will be SOAPed.
ACPE #0129-0000-12-046-L01-P

Mastering Your Message: The Three Ways to Attract New Customers
Gabe Trahan, Senior Director of Store Operations and Marketing, NCPA
Take complete control of your media message! Put into words the very reasons why you chose to become a pharmacist and transpose them into compelling ads that will attract patients who are looking for the care that your pharmacy gives. This program will focus on clearly communicating to patients that you understand their needs and worries and that you want to become a part of their health care equation.
ACPE #0129-0000-12-047-L04-P
Application-based activity

Will a Spoonful of Communication in Pharmacy Practices Help the Medicine Go Down?
Sharon Massen, CPhT, PhD, Professor, Franklin University; Consultant, Massen & Associates
This session will include how to recognize communication problems that may increase conflict, and ways to work cooperatively with pharmacy staff, patients, and others who impact customer service and efficient operation of the pharmacy. Case studies will be shared along with tips for success in managing difficult people and evaluating staff. Audience feedback will be encouraged.
ACPE #0129-0000-12-048-L04-P
Application-based activity

1:30 p.m. (CE Credit per Program:  0.15 CEU)

Innovative Pharmacy Business Plan Competition 2012
Finalist teams and panel of judges TBA
OPA created a Business Plan Competition to cultivate student interest and confidence in developing or buying an independent pharmacy, as well as developing new business venues for future (and current!) pharmacists. Students were invited to submit business plans including the loan request, mission statement, description of the business (legal structure, products or services provided, site analysis), marketing plan and financial reports. Finalists will present their plans to our panel of judges in this session to determine cash awards.  Hear what the students envision and get ideas for your own pharmacy practice.
ACPE #0129-0000-12-049-L04-P
Sponsored by Cardinal Health

Update on Chronic Heart Failure
Rebecca Gryka, PharmD, PhD, Associate Professor and Chair of Pharmaceutical Sciences, Cedarville University School of Pharmacy
This session will review the most common etiologies, pathophysiology and presenting symptoms of chronic heart failure (CHF).  An overview of the pharmacology of the currently accepted classes of drugs used in the treatment of CHF will be presented.  The session will also present the most recent highlights of the Focused Update of the ACC/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults.
ACPE #0129-0000-12-050-L01-P

Meeting the Medication Needs of Underserved Communities through the 340B Drug Pricing Program
Todd D. Sorensen, PharmD, Consultant The HRSA Pharmacy Services Support Center at APhA
The session will provide an overview of the history and intent of the 340B program. Opportunities for partnerships between federally-qualified entities and community pharmacists, program design elements for successful application of the 340B program, and key policy issues currently influencing 340B program application will be discussed.
ACPE #0129-0000-12-051-L04-P

Aspects and Management of Chronic Pain
Mary C. Borovicka, PharmD, BCPS, BCPP; Associate Professor, UT College of Pharmacy and Pharmaceutical Sciences
Part of a three-program module on pain management, this program will focus on the effective management of chronic pain. Topics include an overview of the pathophysiology of chronic pain, proper methods of pain assessment, rational medication selection, managing the side effects, the role of non-pharmacological interventions, consideration with new tamper-resistant/abuse-deterrent opioid formulations and useful tips for managing chronic pain.  Case studies will highlight the presentation.
ACPE #0129-0000-12-052-L01-P
Application-based activity

3:10 p.m. (CE Credit per Program:  0.15 CEU)

Leveraging the Press and Social Media to the Pharmacist’s Advantage
Steve Burson, R.Ph., OPA President, Managed Care Sales Coordinator, The Kroger Co.; Writer/Producer, Kroger Television Network; and Antonio Ciaccia, OPA Director of Marketing & Public Affairs
Pharmacists are experts in drug therapies and are often approached by media to be interviewed on pharmacy-related stories. This program provides a basic understanding of how to prepare for a media interview and techniques to answer questions so that the pharmacist is more confident and savvy when talking to the media. Social media also provides a new and innovative way for pharmacists to educate their community on health-related matters. These online portals bring the unique convergence of personal and professional networks for individuals. This program aims to educate pharmacists on the uses, benefits, and pitfalls of social media to communicate the value of pharmacy to the public.
ACPE #0129-0000-12-053-L04-P

Quality Improvement – A Way to Enhance Patient Safety
Tara M. Modisett, Executive Director, Alliance for Patient Medication Safety
What can pharmacists do to improve patient safety in their practice settings? This session will provide an overview of the types of quality-related events (QRE) – incidents that reach the patient, near misses, and unsafe conditions. Our speaker will address Patient Safety Organization (PSO), elements of a Continuous Quality Improvement (CQI) program, and the benefits and challenges of e-prescribing technology. Ways to implement continuous quality improvement processes in pharmacy practice will be included.
ACPE #0129-0000-12-054-L05-P

Interventions in Heart Failure: A Pharmacist’s Impact
Jodie Fink, PharmD, BCPS, Heart Failure/Transplantation Clinical Specialist, Cleveland Clinic
Heart failure medications are used to improve symptoms and survival in heart failure patients.  Among the multi-disciplinary team, pharmacists emphasize evidence-based medication use, recommend appropriate monitoring, and provide patient education in order to improve patient outcomes.  This presentation will use a series of case studies to describe the impact pharmacists can make in the lives of heart failure patients.
ACPE #0129-0000-12-055-L01-P  

SUNDAY,  April 22

8:15 a.m. (CE Credit per Program:  0.15 CEU)

New Drug Update 2012
(repeated at 9:55 a.m.)
Karen L. Kier, PhD, M.Sc., R.Ph., Director of Assessment and Professor of Clinical Pharmacy Practice, ONU College of Pharmacy
The new drug products recently released to the market can be unique or similar to current therapy. Our speaker will examine the pharmacology and therapeutics of the prescription medications released in the past year. The drugs’ indications, clinical applications, drug interactions, adverse effects and toxicities, and important patient counseling information will be included.
ACPE #0129-0000-12-056-L01-P

Legislative and Regulatory Update for Compounders:  What You Don’t Know Can Hurt You
David G. Miller, R.Ph., Executive Vice President and CEO, International Academy of Compounding Pharmacists
True or false -- the FDA has the right to inspect a pharmacy without a member of the Ohio Board of Pharmacy being present. True or false -- every time you compound a prescription, you are creating an unsafe, illegal drug. True or false -- you can dispense a controlled substance to a doctor to administer to a patient in their offices. At least one of those questions is TRUE. But do you know which one? Whether you consider yourself a compounder or not, this interactive session will make you think twice about what you know about the law!
ACPE #0129-0000-12-057-L04-P
Supported by International Academy of Compounding Pharmacists (IACP)

9:55 a.m. (CE Credit per Program:  0.15 CEU)

New Drug Update 2012
(repeat of 8:15 a.m. program)

Legislative and Regulatory Issues: Impact on Pharmacists
Ernest E. Boyd, PharmD (Hon), CAE and Kelly Vyzral, Lobbyists, Ohio Pharmacists Association
This session will focus on the latest state and federal legislative issues, as well as any regulatory matters of interest to pharmacy. OPA is expecting that audit legislation, PBM regulation, and a number of other significant issues will be introduced early in the 2012 session. Several federal regulatory and legislative actions will have an impact on pharmacists, including DEA’s insistence on dividing the dispensing and consultant activities in long term care, and controlled substance e-prescribing.
ACPE #0129-0000-12-058-L04-P

11:35 a.m. (CE Credit per Program:  0.1 CEU)

OTC Misuse and Abuse
Timothy R. Ulbrich, PharmD, Director of Pharmacy Resident Education and Assistant Professor of Pharmacy Practice, NEOMED
The misuse and abuse of over-the-counter (OTC) products is an ongoing and growing problem in the United States.  People can intentionally misuse an OTC product to experience the psychoactive effects of the medication.  While practitioners are well aware of some medications being abused such as pseudo-ephedrine, they may not be aware of the wide array of other OTC products that are being misused and abused.  During this session, participants will have the opportunity to learn about the current trends in OTC misuse and abuse and brainstorm ideas about how they, as health care professionals, can minimize the extent and impact of this problem.  ACPE #0129-0000-12-059-L01-P

“iPharmacy:” Bringing Your Practice to the 21st Century
Melody Hartzler, R.Ph., PharmD, AE-C, Assistant Professor, Cedarville University School of Pharmacy; and Dustin Hartzler, Website Developer
Our speakers will discuss how to incorporate technology applications available for smart phones and tablet devices into your pharmacy practice.  This interactive session will highlight website development and key features every website should contain. Information will apply to multiple pharmacy practice areas.
ACPE #0129-0000-12-060-L04-P

12:35 p.m.  Conference Adjournment

Printer-Friendly Version